76 results
Page 3 of 4
8-K
EX-2.1
xezaxbk8 42
24 May 23
Pyxis Oncology to Acquire Apexigen
6:59am
8-K
EX-99.1
9bgc3rgwrdvbhokv6ltn
11 May 23
Pyxis Oncology Reports Financial Results for the First Quarter 2023
7:16am
8-K
EX-99.1
rpacnm 3h01
1 Dec 22
Pyxis Oncology Announces FDA Clearance of Two IND Applications
7:03am
8-K
z6ef fwlq6rvy
1 Dec 22
Pyxis Oncology Announces FDA Clearance of Two IND Applications
7:03am
S-3
vhkfrmr3glidoty
1 Nov 22
Shelf registration
4:51pm
S-3
EX-1.2
kxup4i21fwaq
1 Nov 22
Shelf registration
4:51pm
8-K
EX-99.1
9dru7
1 Nov 22
Expands worldwide licensing agreement with Pfizer to obtain additional antibody-drug conjugate (ADC) platform components
7:14am
8-K
EX-99.1
laab3gb1 nwe0d0p
15 Aug 22
Prioritized pipeline to focus on most advanced programs while maintaining financial flexibility to pursue business development opportunities
7:11am
8-K
EX-99.1
mf9qe 6hk9fwte52p
13 May 22
Results of Operations and Financial Condition
8:12am
8-K
EX-99.1
w6z67wq3osviduv
14 Apr 22
Pyxis Oncology Announces Leadership Changes
5:11pm
10-K
urgphvi ysi1
29 Mar 22
Annual report
7:36am
8-K
EX-99.1
wtgc5p
29 Mar 22
Pyxis Oncology Provides Corporate and Financial Update
7:31am
10-Q
EX-3.1
2uz6754mv xqkf
15 Nov 21
Quarterly report
7:54am
10-Q
64ii774u0x2n fu
15 Nov 21
Quarterly report
7:54am